首页> 外文期刊>International braz j urol >A prospective study assessing feasibility of performing percutaneous nephrolithotomy in chronic kidney disease patients - What factors affect the outcome?
【24h】

A prospective study assessing feasibility of performing percutaneous nephrolithotomy in chronic kidney disease patients - What factors affect the outcome?

机译:一项前瞻性研究,评估在慢性肾脏病患者中进行经皮肾镜取石术的可行性-哪些因素影响预后?

获取原文
           

摘要

Objectives To primarily evaluate the functional outcomes of PCNL for bilateral renal calculi/calculi in solitary functioning kidney with Chronic Kidney Disease(CKD). To identify factors affecting the renal replacement therapy following PCNL. Materials and Methods Patients with bilateral renal calculi/calculi in solitary kidney and CKD (eGFR60/s.creatinine2) and Good Performance Status [Eastern Cooperative Oncology Group (ECOG): 0–2] were included in the study. Results A total of 60 patients with CKD who had bilateral renal calculi/calculi in solitary functioning kidney underwent PCNL. At 6 months, eGFR improved or stabilized in 45 (75%) patients, while in 15 (25%) patients eGFR deteriorated. A total of 5 (14.28%) and 2 (25%) patients of CKD stage 4 and 5 respectively had improvement in eGFR as well as CKD stage. Fourteen (82.35%), 21 (60%), 3 (37.5%) patients of CKD stage 3, 4, 5 had improvement in eGFR but not significant enough to cause stage migration. Again 3 (17.65%) , 9 ( 40%) and 3 (37.5%) patients of CKD stage 3, 4, 5 had reduction in eGFR but not significant enough to cause stage migration. None of the patients had worsening of CKD stage. Preoperative CKD stage and eGFR were compared with measurements made at the final follow up visit (6 months). Conclusion Our results indicate that most patients of renal calculi with CKD show improvement or stabilization of renal function with aggressive stone removal. Improvement is more in patients who have mild to moderate CKD. Aggressive management of comorbidities, peri-operative UTI and complications may delay or avoid progression of CKD status in such patients.
机译:目的主要评估PCNL治疗慢性肾病(CKD)的单功能肾中双侧肾结石/结石的功能结局。以确定影响PCNL术后肾脏替代治疗的因素。材料和方法本研究纳入了双侧肾结石/孤立肾结石和CKD(eGFR <60 / s.creatinine> 2)且表现良好的患者[东部合作肿瘤小组(ECOG):0-2]。结果总共60例患有CKD的双侧肾结石/孤立功能性肾结石患者接受了PCNL。在6个月时,eGFR改善或稳定在45(75%)名患者中,而15名(25%)患者的eGFR恶化。 CKD 4期和5期的5名(14.28%)和2名(25%)患者的eGFR和CKD期均有改善。 CKD 3、4、5期的14例(82.35%),21例(60%),3例(37.5%)患者的eGFR有所改善,但不足以引起阶段性迁移。 CKD 3、4、5期的3例(17.65%),9例(40%)和3例(37.5%)的eGFR降低,但不足以引起阶段性迁移。所有患者均未出现CKD分期恶化。将术前CKD分期和eGFR与最后一次随访(6个月)时的测量值进行比较。结论我们的结果表明,大多数伴有CKD的肾结石患者表现出改善或稳定的肾功能,并积极切除结石。轻度至中度CKD患者的改善更大。对合并症,围手术期尿路感染和并发症的积极处理可能会延迟或避免此类患者的CKD状态恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号